Cellular cholesterol transport proteins in diabetic nephropathy

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Tsun, Joseph G S ^a   Yung, Susan ^a   Chau, Mel K M ^a   Shiu, Sammy W M ^a   Chan, Tak Mao ^a   Tan, Kathryn C B ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; ABC TRANSPORTER; CHOLESTEROL; GLUCOSE BLOOD LEVEL; LIPID; SCAVENGER RECEPTOR B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; LIPID STORAGE; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BLOOD; DBA MOUSE; DISEASE MODEL; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY; METABOLISM; MORTALITY; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CHOLESTEROL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIPIDS; MALE; MICE, INBRED DBA; SCAVENGER RECEPTORS, CLASS B;

EID: 84907450503     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105787     Document Type: Article

References (26)

1. Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2: 1309-1311. (Pubitemid 13240921)
2. Jandeleit-Dahm K, Cao Z, Cox AJ, Kelly DJ, Gilbert RE, et al. (1999) Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int Suppl 71: S31-36. (Pubitemid 29304809)
3. Wang Z, Jiang T, Li J, Proctor G, McManaman JL, et al. (2005) Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 54: 2328-2335. (Pubitemid 41134259)
4. Lee HS, Lee JS, Koh HI, Ko KW (1991) Intraglomerular lipid deposition in routine biopsies. Clin Nephrol 36: 67-75.
5. Sun L, Halaihel N, Zhang W, Rogers T, Levi M (2002) Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 277: 18919-18927. (Pubitemid 34952453)
6. Abrass CK (2006) Lipid metabolism and renal disease. Contrib Nephrol 151: 106-121.
7. Gröne HJ, Hohbach J, Gröne EF (1996) Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins. Kidney Int Suppl 54: S18-22.
8. Zager RA, Johnson A (2001) Renal cortical cholesterol accumulation is an integral component of the systemic stress response. Kidney Int 60: 2299-2310. (Pubitemid 33070472)
9. Takemura T, Yoshioka K, Aya N, Murakami K, Matumoto A, et al. (1993) Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43: 918-927. (Pubitemid 23105228)
10. Schlondorff D (1993) Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22: 72-82.
11. Adorni MP, Zimetti F, Billheimer JT, Wang N, Rader DJ, et al. (2007) The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res 48: 2453-2462. (Pubitemid 350058756)
12. Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, et al. (2012) Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125: 1905-1919.
13. Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, et al. (2003) PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol 14: 593-600. (Pubitemid 36246002)
14. Wheeler DC, Chana RS (1993) Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 19: 149-164. (Pubitemid 23305542)
15. Anami Y, Kobori S, Sakai M, Kasho M, Nishikawa T, et al. (1997) Human beta-migrating very low density lipoprotein induces foam cell formation in human mesangial cells. Atherosclerosis 135: 225-234. (Pubitemid 28015189)
16. Zager RA, Johnson AC, Hanson SY, Shah VO (2003) Acute tubular injury causes dysregulation of cellular cholesterol transport proteins. Am J Pathol 163: 313-320. (Pubitemid 36759616)
17. Tang C, Kanter JE, Bornfeldt KE, Leboeuf RC, Oram JF (2010) Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res 51: 1719-1728.
18. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, et al. (1994) HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57. (Pubitemid 24045991)
19. Nieland TJ, Penman M, Dori L, Krieger M, Kirchhausen T (2002) Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. PNAS 99: 15422-15427. (Pubitemid 35403950)
20. Yung S, Tsang RC, Leung JK, Chan TM (2006) Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta. Kidney Int 69: 272-280. (Pubitemid 43323077)
21. Yung S, Zhang Q, Zhang CZ, Chan KW, Lui SL, et al. (2009) Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis Rheum 60: 2071-2082.
22. Song KH, Park J, Ha H (2012) High glucose increases mesangial lipid accumulation via impaired cholesterol transporters. Transplant Proc 44: 1021-1025.
23. Johnson AC, Yabu JM, Hanson S, Shah VO, Zager RA (2003) Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression. Am J Pathol 162: 283-291. (Pubitemid 36042010)
24. Kim HJ, Vaziri ND (2009) Sterol regulatory element-binding proteins, liver X receptor, ABCA1 transporter, CD36, scavenger receptors A1 and B1 in nephrotic kidney. Am J Nephrol 29: 607-614.
25. Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND (2009) Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296: F1297-1306.
26. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, et al. (2006) Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55: 2502-2509. (Pubitemid 44871150)